ConverGene's Unattributed Round

ConverGene raised a round of funding on April 08, 2014.

ConverGene has discovered and developed a propriety library of small molecules that have profound effects on the MYC gene, a critical oncogene that controls progression of cancer. From this compound l…

Articles about ConverGene's Unattributed Round: